149 related articles for article (PubMed ID: 16831366)
1. [Disfigurement of p16INK4A gene expression in development of ovarian cancer and the mechanism].
Li M; Huang ZJ; Dong WH; Li XY; Wang XY; He XH; Wang H; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):408-12. PubMed ID: 16831366
[TBL] [Abstract][Full Text] [Related]
2. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
Wang Z; Li M; Lu S; Zhang Y; Wang H
Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between RAR-beta gene expression defect and its methylation].
Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
[TBL] [Abstract][Full Text] [Related]
5. Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
Liu Z; Wang LE; Wang L; Lu KH; Mills GB; Bondy ML; Wei Q
Clin Cancer Res; 2005 Jul; 11(13):4968-76. PubMed ID: 16000597
[TBL] [Abstract][Full Text] [Related]
6. Demethylation by 5-aza-2'-deoxycytidine (5-azadC) of p16INK4A gene results in downregulation of vascular endothelial growth factor expression in human lung cancer cell lines.
Miki K; Shimizu E; Yano S; Tani K; Sone S
Oncol Res; 2001; 12(8):335-42. PubMed ID: 11589304
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
[TBL] [Abstract][Full Text] [Related]
8. [Reversal effect of 5-aza-2-deoxycytidine on the maternally expressed gene 3 promoter hypermethylation and its inhibitory effect on the proliferation of epithelial ovarian cancer cells].
Li J; Zhou D; Wang Z; Tan L; Zhou Y; Li J; Sheng X
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):324-9. PubMed ID: 26463020
[TBL] [Abstract][Full Text] [Related]
9. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
[TBL] [Abstract][Full Text] [Related]
10. [Demethylation of estrogen receptor gene and its re-expression in estrogen receptor-negative breast].
Wang R; Li LW; Wang RL; Fan QX; Zhao PR; Wang LX; Lu SH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):894-7. PubMed ID: 17533738
[TBL] [Abstract][Full Text] [Related]
11. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status.
Xiong J; Epstein RJ
Mol Cancer Ther; 2009 Apr; 8(4):779-85. PubMed ID: 19372550
[TBL] [Abstract][Full Text] [Related]
13. 5-Aza-2'-deoxycytidine leads to down-regulation of aberrant p16INK4A RNA transcripts and restores the functional retinoblastoma protein pathway in hepatocellular carcinoma cell lines.
Suh SI; Pyun HY; Cho JW; Baek WK; Park JB; Kwon T; Park JW; Suh MH; Carson DA
Cancer Lett; 2000 Nov; 160(1):81-8. PubMed ID: 11098088
[TBL] [Abstract][Full Text] [Related]
14. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
Arnold CN; Goel A; Boland CR
Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the PTEN gene in ovarian cancer cell lines.
Schöndorf T; Ebert MP; Hoffmann J; Becker M; Moser N; Pur S; Göhring UJ; Weisshaar MP
Cancer Lett; 2004 Apr; 207(2):215-20. PubMed ID: 15072831
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of 5-Aza-2'-deoxycytidine on human nasopharyngeal carcinoma xenograft in nude mice].
Zhang S; Kong WJ; Wang YJ; Han YC; Zhang D
Ai Zheng; 2005 Oct; 24(10):1201-5. PubMed ID: 16219133
[TBL] [Abstract][Full Text] [Related]
17. [Methylation and demethylation of SOX2 gene promoter in BGC-823 gastric cancer cells].
Wei B; Liu G; Cai HL; Li GP; Huang HQ; Luo Q; Huang ZJ
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(32):2548-53. PubMed ID: 27596549
[TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter methylation of SPARC in ovarian cancer.
Socha MJ; Said N; Dai Y; Kwong J; Ramalingam P; Trieu V; Desai N; Mok SC; Motamed K
Neoplasia; 2009 Feb; 11(2):126-35. PubMed ID: 19177197
[TBL] [Abstract][Full Text] [Related]
19. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15.
Ishiguro M; Iida S; Uetake H; Morita S; Makino H; Kato K; Takagi Y; Enomoto M; Sugihara K
Ann Surg Oncol; 2007 May; 14(5):1752-62. PubMed ID: 17195906
[TBL] [Abstract][Full Text] [Related]
20. [5-aza-2'-deoxycytidine-induced inhibition of CDH13 expression and its inhibitory effect on methylation status in human colon cancer cells in vitro and on growth of xenograft in nude mice].
Ren JZ; Huo JR
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):6-10. PubMed ID: 22490847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
